Table 3.

Striatal [3H]WIN 35,428 binding densities in monkeys during the long-term phase of cocaine self-administration 3-a

Brain regionsControl n = 3Cocaine 0.03 mg/kg/inj n = 3Percent difference3-b
Rostral precommissural striatum
 Dorsolateral caudate86.7  ± 12102.6  ± 1218%
 Dorsomedial caudate102.2  ± 4124.9  ± 1222%
 Ventral caudate90.0  ± 10116.8  ± 730%
 Dorsal putamen110.9  ± 13135.2  ± 1622%
 Central putamen98.8  ± 13131.4  ± 1033%
 Ventral putamen85.4  ± 8103.8  ± 521%
 Accumbens54.5  ± 163.3  ± 816%
Caudal precommissural striatum
 Dorsolateral caudate108.0  ± 19110.7  ± 82%
 Dorsomedial caudate125.0  ± 16144.2  ± 1315%
 Ventral caudate86.0  ± 6124.1  ± 13-16544%
 Dorsal putamen114.3  ± 16140.9  ± 1223%
 Central putamen101.4  ± 17131.9  ± 530%
 Ventral putamen83.9  ± 11108.9  ± 430%
 Accumbens (shell)51.9  ± 159.7  ± 33-15015%
 Accumbens (core)59.7  ± 483.2  ± 33-16039%
 Olfactory tubercle55.4  ± 473.4  ± 23-16033%
  • F3-a Data represent femtomoles per milligram, wet weight tissue and are expressed as mean ± SEM.

  • F3-b Percent difference from control values.

  • F3-150 p < 0.05;

  • F3-160 p < 0.01;

  • F3-165 p < 0.005 different from control. Statistical analysis was performed for each brain region using Student's t test to compare drug treatments with controls.

  • inj, Injection.